SIRT7 and infarction: Astragaloside IV, a major active compound of Astragalus, may promote angiogenesis via the silencing regulatory protein 7 (SIRT7)/vascular endothelial growth factor A (VEGFA) signaling pathway to improve brain tissue damage postcerebral infarction [24].